ABSORICA: payments to doctors
Payments that named ABSORICA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $350K
- Providers
- 2,101
- Transactions
- 4,601
- Average per transaction
- $76
The per-transaction average — $76 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,101 providers the average total is $167, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | $342,975 | 97.9% |
| TARO Pharmaceuticals USA, Inc. | $4,153 | 1.2% |
| SUN Pharmaceutical Industries Inc. | $3,200 | 0.9% |